Trident Texofab Reaches New High Amid Strong Small-Cap Market Performance

Trident Texofab, a microcap player in the Garments & Apparels industry, has shown significant activity today, reaching a new 52-week high of Rs. 218.95. This milestone was achieved on June 9, 2025, marking a notable performance as the stock outperformed its sector by 2.43%. Over the past three days, Trident Texofab has demonstrated a consistent upward trend, accumulating a total return of 4.81%.
Intraday trading saw the stock hit a high of Rs. 218.95, reflecting a gain of 4.29%, while it also experienced a low of Rs. 205.5, down by 2.12%. Notably, Trident Texofab is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong market position.

In the broader market context, the Sensex opened higher at 82,574.55, gaining 385.56 points, and is currently trading at 82,438.59. The index is nearing its own 52-week high, with small-cap stocks leading the market today. Over the past year, Trident Texofab has delivered an impressive performance, soaring 362.02%, significantly outpacing the Sensex's 7.49% increase. The stock's 52-week low stands at Rs. 36.15.